Congenital aniridia

Search Trials
A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)
Status:
Recruiting
Last Changed:
Aug 7, 2019
First Changed:
Apr 5, 2019
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
A Placebo-controlled Study of Maralixibat (SHP625) in Pediatric Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC)
Status:
Withdrawn
Last Changed:
Mar 18, 2019
First Changed:
Nov 27, 2017
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
Study of Ataluren in Participants With Nonsense Mutation Aniridia
Status:
Active, not recruiting
Last Changed:
Sep 2, 2019
First Changed:
Jan 6, 2016
Disease(s):
Aniridia
Intervention(s):
AtalurenPlacebo
Second-line Therapy of Unresectable Cholangiocarcinoma by RADIOEMBOLIZATION
Status:
Terminated
Last Changed:
Aug 7, 2013
First Changed:
Jun 28, 2011
Disease(s):
Cholestasis, Progressive Familial Intrahepatic 3
Intervention(s):
Yttrium microsphere injection
Ultrahigh-resolution Optical Coherence Tomography Imaging of the Anterior Eye Segment Structures
Status:
Enrolling by invitation
Last Changed:
Aug 20, 2019
First Changed:
Mar 12, 2018
Disease(s):
Meibomian Gland Dysfunction
Intervention(s):
Ultrahigh resolution Spectral Domain OCT

Connect. Empower. Inspire.